Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1394studies shown
Showing 626-650 of 1,394
CompletedNCT03925038

Electronic Communication Augmented Mental Health Care

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

DepressionOtherFrom 12 Years to 100 Years
Countries
United States
Sponsor
Johns Hopkins University
Condition
Depression
CompletedNCT04427137

Accelerated LFR for Bipolar Patients During the COVID-19 Pandemic

This study exists to see whether the medication COVID-19 is workable and worth testing more broadly. Researchers are trying to understand whether the medication COVID-19 can better prevent setbacks and support longer-term stability.

BipolarityOtherOver 18 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Bipolarity
CompletedNCT00221429

Lithium Versus Divalproex for Treating Pediatric Bipolarity

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.

BipolarityOtherFrom 7 Years to 18 Years
Countries
United States
Sponsor
Children's Hospital Medical Center, Cincinnati
Condition
Bipolarity
CompletedNCT03509181

Augmenting Hospitalization for Serious Mental Illness: Cognitive Bias Modification

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, is workable and worth testing more broadly. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

BipolarityOtherOver 18 Years
Countries
United States
Sponsor
Mclean Hospital
Condition
Bipolarity
CompletedNCT06113887

The Effect of Acceptance and Commitment of Bipolarity Patients

This study exists to understand how cognitive behavioural therapy, a structured talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

BipolarityOtherFrom 18 Years to 65 Years
Countries
Turkey
Sponsor
University of Gaziantep
Condition
Bipolarity
TerminatedNCT03508427

Toi Même: a Mobile System for Measuring Bipolar Illness

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can better prevent setbacks and support longer-term stability.

BipolarityOtherFrom 18 Years to 60 Years
Countries
France
Sponsor
Institut Pasteur
Condition
Bipolarity
CompletedNCT04477187

Clinical Assessment of Skin Tightening and Contour Change of Submental Tissue Using Bipolar Radiofrequency Microneedling

This study exists to understand whether a digital app or remote support tool is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.

BipolarityOtherFrom 21 Years to 70 Years
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Condition
Bipolarity
CompletedNCT00154323

The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Bipolarity I or II This Study is Not Being Conducted in the United States.

This study exists to understand whether a therapy or guided support program is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.

BipolarityOtherOver 18 Years
Countries
Global
Sponsor
Novartis
Condition
Bipolarity
CompletedNCT03220776

Imaging GABAergic/Glutamatergic Drugs in Bipolar Alcoholics Alcoholics

This study exists to explore whether acceptance and commitment therapy, a talking treatment, could improve care and understanding. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can work better when mental health difficulties overlap with substance use.

BipolarityOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Medical University of South Carolina
Condition
Bipolarity
CompletedNCT01655030

Creatine Monohydrate as Adjuvant Therapy for Depression in bipolarity

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand whether a therapy or guided support program can better support energy, concentration, and everyday functioning.

DepressionOtherFrom 18 Years to 60 Years
Countries
Brazil
Sponsor
University of Sao Paulo
Condition
Depression
CompletedNCT04834999

Validation of Instruments for Clinical Trial on Patients With Bipolarity in Rwanda

This study exists to see whether psychoeducation, a guided learning and support program, can make care clearer and more responsive. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can improve attention, thinking, or day-to-day functioning.

BipolarityOtherOver 18 Years
Countries
Rwanda
Sponsor
University of Aarhus
Condition
Bipolarity
CompletedNCT05357859

Vitamin D for Cognition in Bipolarity

This study exists to compare options and see whether questionnaires and follow-up reports offers something meaningfully different. Researchers are trying to understand whether questionnaires and follow-up reports can improve attention, thinking, or day-to-day functioning.

BipolarityOtherFrom 20 Years to 65 Years
Countries
Taiwan
Sponsor
Taipei City Hospital
Condition
Bipolarity
CompletedNCT04987658

Phase 1 Study of OLZ/SAM in Pediatric Subjects With Bipolarity I

This study exists to better understand the safety of the medication OLZ and how manageable it feels in practice. Researchers are trying to understand how people respond to the medication OLZ in practice and what may need to be adjusted.

BipolarityOtherFrom 10 Years to 12 Years
Countries
United States
Sponsor
Alkermes, Inc.
Condition
Bipolarity
CompletedNCT04030143

A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolarity type I

This study exists to better understand the safety of the medication Multiple-doses and how manageable it feels in practice. Researchers are trying to understand how people respond to the medication Multiple-doses in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 64 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
CompletedNCT02466685

Testing the Ability of JNJ-18038683 to Improve Cognition and Reduce Depressive Symptoms in Stable Bipolar Patients

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

DepressionOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
Herbert Meltzer
Condition
Depression
CompletedNCT01371383

The Effect of Omega-3 Polyunsaturated Fatty Acids in the Treatment and Prevention of Relapse of Bipolarity

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can better prevent setbacks and support longer-term stability.

BipolarityOtherFrom 18 Years to 65 Years
Countries
Taiwan
Sponsor
National Science and Technology Council, Taiwan
Condition
Bipolarity
CompletedNCT03902613

18F-DOPA PET to Elucidate the Antidepressant Mechanism of Lurasidone in Bipolarity

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.

BipolarityOtherFrom 18 Years to 50 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Bipolarity
CompletedNCT03160664

Magnetic Seizure Therapy for Bipolar Mania

This study exists to understand whether a therapy or guided support program is both safe enough and useful enough to take further. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

BipolarityOtherFrom 18 Years to 55 Years
Countries
China
Sponsor
Shanghai Mental Health Center
Condition
Bipolarity
TerminatedNCT06105294

Time-Restricted Eating and Bipolarity

This study exists to see whether a medication treatment is workable and worth testing more broadly. Researchers are trying to understand whether a medication treatment can improve sleep, daily rhythms, and longer-term stability.

BipolarityOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of California, Berkeley
Condition
Bipolarity
CompletedNCT06099132

Antagonist Activation Measurement at the Ankle Using High-density and Bipolar Surface EMG in Chronic Hemiparesis

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.

BipolarityOtherOver 18 Years
Countries
Global
Sponsor
Henri Mondor University Hospital
Condition
Bipolarity
CompletedNCT04874974

Feasibility of a Novel Process-based Treatment for Patients With Psychosis

This study exists to see whether acceptance and commitment therapy, a talking treatment, is workable and worth testing more broadly. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 70 Years
Countries
Germany
Sponsor
Max-Planck-Institute of Psychiatry
Condition
Schizophrenia